Protocols & References
Mechanism-level overviews of the compounds researchers ask about most — sourced from published preclinical literature, with explicit limitations noted throughout. Nothing here is a health, dosing or treatment claim; it's a summary of what the current research does and doesn't show.
BPC-157: Mechanisms of Action and Research Applications
A deep-dive into Body Protection Compound-157, its gastroprotective origins, and its expanding role in musculoskeletal and neurological recovery research.
Understanding GLP-1 Receptor Agonists in Metabolic Research
A comprehensive review of glucagon-like peptide-1 receptor signalling, the structural biology of synthetic agonists, and emerging metabolic research directions.
The Chemistry of Peptide Degradation: Why Storage Conditions Matter
A mechanistic look at why peptides degrade in storage: the oxidation, deamidation, and aggregation pathways behind the temperature and handling variables researchers control for.
Epithalon and Telomere Biology: A Research Overview
Exploring the tetrapeptide Epithalon, its interactions with telomerase, pineal gland regulation, and its position within the broader landscape of longevity research.
Semax and Cognitive Enhancement Research
A systematic review of Semax pharmacology, its BDNF-upregulating and neuroprotective mechanisms, and the clinical research landscape from its origins in Soviet neuroscience.
Solvent Selection Chemistry: Why Peptide Polarity Dictates Reconstitution
Why solvent choice for peptide reconstitution isn't arbitrary: the charge, hydrophobicity, and isoelectric-point chemistry that determines which solvent a given sequence needs.
Melanotan II: Melanocortin Receptor Pharmacology and Research History
How a 1980s photoprotection research programme at the University of Arizona produced one of the most-studied non-selective melanocortin agonists — and eventually led, via a more selective descendant, to an FDA-approved drug.
Tesamorelin: GHRH Analog Research in Metabolic and Visceral Fat Studies
A research overview of Tesamorelin, a stabilized GHRH(1-44) analog studied for its effects on visceral adipose tissue, IGF-1 signaling, and pulsatile growth hormone release.
IGF-1 LR3: Extended Half-Life Analog in Tissue Growth Research
How a 13-amino-acid B-domain extension and single point mutation transform native IGF-1 into a long-acting research tool for studying anabolic signaling and satellite cell activity.
GHK-Cu: Copper-Binding Tripeptide Research in Skin and Wound Biology
A research overview of GHK-Cu, a naturally occurring copper-binding tripeptide studied for its effects on collagen remodeling, gene expression, and wound repair.
TB-500: The Thymosin Beta-4 Actin-Binding Fragment in Repair Research
How a 43-amino-acid synthetic fragment of Thymosin Beta-4 became a widely studied tool compound for actin dynamics, cell migration, and tissue-repair research.
Sermorelin: GHRH(1-29) Research and the Foundations of GH Secretagogue Study
A research overview of Sermorelin, the 29-amino-acid GHRH fragment that established the pharmacological basis for the entire class of GH-secretagogue research compounds.
SS-31 (Elamipretide): Mitochondria-Targeted Peptide Research
A research overview of SS-31, a Szeto-Schiller peptide engineered to concentrate in the inner mitochondrial membrane and studied for its effects on cardiolipin stability and oxidative stress.
What Research Peptides Actually Cost — And Why Price Per Milligram Tells You Almost Nothing
Two vials of the same compound, same milligram label, can differ fourfold in price. The gap is rarely margin — synthesis length, purification passes, analytical testing and what the label actually weighs explain almost all of the spread.
How Research Peptide Vials Fail Quality Control — And the Six Checks That Catch It
Research peptide purity, net content, identity and pyrogen load are four independent variables. A vial can pass one and fail the other three without the certificate saying anything untrue.
BPC-157 vs TB-500 — What the Preclinical Evidence Actually Compares
BPC-157 vs TB-500 is routinely framed as a choice between interchangeable compounds, or as a natural pairing. The published literature supports neither reading — and in July 2026 they were finally tested head to head.
Do Research Peptides Need Refrigeration? Cold Chain, Customs and Carriers
The published stability data say lyophilised material is far more robust in transit than the ice packs imply, the real thermal risk sits in customs hold rather than scheduled transit, and dry ice is more dangerous to material in solution than an ambient excursion is.